A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio

The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. We...

Full description

Saved in:
Bibliographic Details
Published inCancer management and research Vol. 11; pp. 4719 - 4728
Main Authors Fan, Ningbo, Chen, Dongni, Zheng, Jiabo, Wen, Zhesheng, Lin, Peng
Format Journal Article
LanguageEnglish
Published New Zealand Dove Medical Press Limited 01.05.2019
Dove
Dove Medical Press
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test. The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ =7.267, =0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ =5.414, =0.020) and tended to die within one year (23.5% vs 10.9%, χ =10.871, =0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, =0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, =0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073-1.952, =0.015), DFS (HR: 1.445, 95%CI: 1.084-1.925, =0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157-3.898, =0.015). The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy.
AbstractList Ningbo Fan,1,* Dongni Chen,1,* Jiabo Zheng,2 Zhesheng Wen,1 Peng Lin11Department of Thoracic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou 510060, People's Republic of China; 2Department of Gastrointestinal Surgery, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou 510080, People's Republic of China*These authors contributed equally to this workPurpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy.Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test.Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ2=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ2=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%, χ2=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073-1.952, P=0.015), DFS (HR: 1.445, 95%CI: 1.084-1.925, P=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157-3.898, P=0.015).Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy.Keywords: esophageal squamous cell carcinoma, prognostic indicator, fibrinogen, lymphocyte
The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test. The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ =7.267, =0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ =5.414, =0.020) and tended to die within one year (23.5% vs 10.9%, χ =10.871, =0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, =0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, =0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073-1.952, =0.015), DFS (HR: 1.445, 95%CI: 1.084-1.925, =0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157-3.898, =0.015). The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy.
Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan–Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ 2 =7.267, P =0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ 2 =5.414, P =0.020) and tended to die within one year (23.5% vs 10.9%, χ 2 =10.871, P =0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P =0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P =0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073–1.952, P =0.015), DFS (HR: 1.445, 95%CI: 1.084–1.925, P =0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157–3.898, P =0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy.
Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low ([less than or equal to]3.03) group, the FLR-high (>3.03) group included older patients ([chi square]=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, [chi square]=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%, [chi square]=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073-1.952, P=0.015), DFS (HR: 1.445, 95%CI: 1.084-1.925, P=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157-3.898, P=0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy. Keywords: esophageal squamous cell carcinoma, prognostic indicator, fibrinogen, lymphocyte
Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ2=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ2=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%, χ2=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073-1.952, P=0.015), DFS (HR: 1.445, 95%CI: 1.084-1.925, P=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157-3.898, P=0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy.Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic effect of fibrinogen-to-lymphocyte ratio (FLR) in esophageal squamous cell carcinoma (ESCC) patients who underwent radical esophagectomy. Patients and methods: We retrospectively reviewed 673 consecutive patients with ESCC who underwent radical esophagectomy from January 2009 to December 2012 at a major cancer hospital in Guangzhou, southern China. The cutoff points were defined by the X-tile software. The prognostic value of FLR for overall survival (OS), disease-free survival (DFS), and first-year mortality after surgery were analyzed using Cox proportional hazard regression model and logistic regression model. Survival was estimated by the Kaplan-Meier estimator and compared using the log-rank test. Results: The optimal cutoff point of FLR was 3.03. Compared with the FLR-low (≤3.03) group, the FLR-high (>3.03) group included older patients (χ2=7.267, P=0.007), showed higher postoperative overall morbidity (24.7% vs 14.8%, χ2=5.414, P=0.020) and tended to die within one year (23.5% vs 10.9%, χ2=10.871, P=0.001). The FLR-high group showed significant lower 5-year OS rates (41.2% vs 53.7%, log-rank=6.827, P=0.009) and 5-year DFS rates (35.3% vs 48.0%, log-rank=5.954, P=0.015) than the FLR-low group. Multivariate analyses suggested that high FLR was an independent negative predictor of OS (HR: 1.448, 95%CI: 1.073-1.952, P=0.015), DFS (HR: 1.445, 95%CI: 1.084-1.925, P=0.012) and first-year mortality (HR: 2.123, 95%CI: 1.157-3.898, P=0.015). Conclusion: The preoperative FLR level could be used as a simple, noninvasive, inexpensive, and potentially effective indicator to evaluate the prognosis of ESCC patients following radical esophagectomy.
Audience Academic
Author Zheng, Jiabo
Lin, Peng
Fan, Ningbo
Chen, Dongni
Wen, Zhesheng
Author_xml – sequence: 1
  givenname: Ningbo
  surname: Fan
  fullname: Fan, Ningbo
– sequence: 2
  givenname: Dongni
  surname: Chen
  fullname: Chen, Dongni
– sequence: 3
  givenname: Jiabo
  orcidid: 0000-0001-7834-5103
  surname: Zheng
  fullname: Zheng, Jiabo
– sequence: 4
  givenname: Zhesheng
  orcidid: 0000-0002-0065-7542
  surname: Wen
  fullname: Wen, Zhesheng
– sequence: 5
  givenname: Peng
  orcidid: 0000-0003-3760-5575
  surname: Lin
  fullname: Lin, Peng
BackLink https://www.ncbi.nlm.nih.gov/pubmed/31213896$$D View this record in MEDLINE/PubMed
BookMark eNptkkuP0zAUhSM0iJkp7FgjS2xYkOJXkoYFUlXxGGkQEo-15TjXrUdJnLHdov4m_iQ3tDOaolEWfn3n-PrmXGZngx8gy14yOudMVu9WX5ff5z84lbVYPMkuGKvqnAnOzx7Mz7PLGG8oLWsm5LPsXDDOxKIuL7I_SzL4HXRkDOBHCDq5HZCx07HXxA2tMzr5QJKfAFwlHP168BEisXgwogCGFMlvlzYEoh83eg26I_F2q3u_jcRA1xGjg3GDR09tEwQS9OTc3QtM8v3-PbGuCYitYciTz7t9P2682ScgU13-efbU6i7Ci-M4y359-vhz9SW__vb5arW8zk3BqpTb2hrGBRNtUzKo2qIG0EbLsmgp062hRoLQhWwlL3FiLa8kaEHrAlopKyZm2dXBt_X6Ro3B9TrslddO_dvwYa10SM50oCposJWW0oqiYW0bA2XL8T5tedPgPbPsw8Fr3DY9tAZ7FXR3Ynp6MriNWvudKgtRVrRGgzdHg-BvtxCT6l2ceqoHwPYqzqWQC1nVEtHXB3StsTQ3WI-OZsLVsmS0QKqskJo_QuHXQu8MZss63D8RvHr4hPva70KEAD8AJvgYA1hlXJp-2PQi1ylG1ZRUNSVVHZOKorf_ie58H8X_At6m73Q
CitedBy_id crossref_primary_10_3390_jpm11111228
crossref_primary_10_3389_fonc_2022_1003845
crossref_primary_10_11569_wcjd_v27_i18_1133
crossref_primary_10_1245_s10434_021_10848_8
crossref_primary_10_2147_IJGM_S407833
crossref_primary_10_3389_fonc_2020_00797
crossref_primary_10_3389_fonc_2022_992929
ContentType Journal Article
Copyright COPYRIGHT 2019 Dove Medical Press Limited
2019 Fan et al. 2019 Fan et al.
Copyright_xml – notice: COPYRIGHT 2019 Dove Medical Press Limited
– notice: 2019 Fan et al. 2019 Fan et al.
DBID AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.2147/CMAR.S204938
DatabaseName CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate Fan et al
EISSN 1179-1322
EndPage 4728
ExternalDocumentID oai_doaj_org_article_7eb121f007054d9fbce6d2eeaaf2bb4e
PMC6536709
A610584767
31213896
10_2147_CMAR_S204938
Genre Journal Article
GeographicLocations China
GeographicLocations_xml – name: China
GroupedDBID ---
0YH
29B
2WC
53G
5VS
7X7
8FI
8FJ
8G5
AAYXX
ABUWG
ACGFO
ADBBV
ADRAZ
AFKRA
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BCNDV
BENPR
BPHCQ
BVXVI
C1A
CCPQU
CITATION
DIK
DWQXO
E3Z
EBD
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HMCUK
HYE
IAO
IHR
IPNFZ
ITC
KQ8
M2O
M48
M~E
O5R
O5S
OK1
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
TDBHL
TR2
UKHRP
VDV
NPM
PMFND
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c517t-f9fc12313db61e7d59eeaca465d01adc0c4e3a54d426e3aff274ea3095ed44713
IEDL.DBID M48
ISSN 1179-1322
IngestDate Wed Aug 27 01:20:35 EDT 2025
Thu Aug 21 18:13:49 EDT 2025
Thu Jul 10 18:00:38 EDT 2025
Tue Jun 17 20:27:49 EDT 2025
Tue Jun 10 20:27:04 EDT 2025
Thu Jan 02 23:01:11 EST 2025
Tue Jul 01 03:18:23 EDT 2025
Thu Apr 24 23:12:10 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords esophageal squamous cell carcinoma
fibrinogen
prognostic indicator
lymphocyte
Language English
License http://creativecommons.org/licenses/by-nc/3.0
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c517t-f9fc12313db61e7d59eeaca465d01adc0c4e3a54d426e3aff274ea3095ed44713
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work
ORCID 0000-0001-7834-5103
0000-0002-0065-7542
0000-0003-3760-5575
0000-0002-1622-6747
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.2147/CMAR.S204938
PMID 31213896
PQID 2243484794
PQPubID 23479
PageCount 10
ParticipantIDs doaj_primary_oai_doaj_org_article_7eb121f007054d9fbce6d2eeaaf2bb4e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6536709
proquest_miscellaneous_2243484794
gale_infotracmisc_A610584767
gale_infotracacademiconefile_A610584767
pubmed_primary_31213896
crossref_citationtrail_10_2147_CMAR_S204938
crossref_primary_10_2147_CMAR_S204938
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20190501
PublicationDateYYYYMMDD 2019-05-01
PublicationDate_xml – month: 05
  year: 2019
  text: 20190501
  day: 01
PublicationDecade 2010
PublicationPlace New Zealand
PublicationPlace_xml – name: New Zealand
PublicationTitle Cancer management and research
PublicationTitleAlternate Cancer Manag Res
PublicationYear 2019
Publisher Dove Medical Press Limited
Dove
Dove Medical Press
Publisher_xml – name: Dove Medical Press Limited
– name: Dove
– name: Dove Medical Press
SSID ssj0069134
Score 2.1992154
Snippet The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the prognostic...
Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the...
Purpose: The inflammatory microenvironment and hemostatic system are involved in several stages of tumor progression. The aim of this study was to assess the...
Ningbo Fan,1,* Dongni Chen,1,* Jiabo Zheng,2 Zhesheng Wen,1 Peng Lin11Department of Thoracic Oncology, State Key Laboratory of Oncology in South China,...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 4719
SubjectTerms Analysis
Carcinoma
China
Development and progression
Elderly patients
Esophageal cancer
esophageal squamous cell carcinoma
Fibrin
Fibrinogen
Health aspects
lymphocyte
Lymphocytes
Medical research
Morbidity
Mortality
Original Research
Prognosis
prognostic indicator
Squamous cell carcinoma
Surgery
Tumors
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Nj9MwELXQHhAXxDeBBRkJxAGZrRPni1tZsVohlQOw0t4sxx4LpK5d2ixSfxN_kpk4rRohxIVbW7utk3mZebbHbxh72eUNIE32Arm8o6UbEEYpI1QnS1c6knyidcjFp-r8Qn28LC8PSn1RTliSB0437qRGZ5JLT7I0pXKt7yxULgcwxuddp4C8L8a83WQq-eBqt5-McBM030op71ST5-R0Mf_89kuOzJjOpBwEo0Gz_0_PfBCapmmTB3Ho7A67PRJIPk8Dv8tuQLjHbi7GLfL77Nech_gTlny1hriCJOzNV0iSrwynDWpL02zeR-qA73pOKVohbmDDkcDyUWh1w2mFlgNVOUCXg_-4-XFtaJ2A01o_t1SDKET8zaHKOF-bYcNn_wXbx6vtO-7pREGIiFLRR7HcInai3fbAB-A9YBdnH76enouxIoOwpax74VtvMdTJwnWVhNqVLRrCGlWVbiaNszOroDBoJ4z7-MJ7nPOCKZDGgVMYBouH7CjEAI8Z9-go2qpBD4PYsE42jSR2IjuXu1ljZhl7szONtqNcOVXNWGqctpAhNRlSj4bM2Kt971WS6fhLv_dk5X0fEtcePkDI6RFy-l-Qy9hrwogmF4BDsmY8yYAXRmJaeo6UlHafqzpjx5Oe-OjaSfOLHco0NVG-WwC0pEZiVaiG1P8z9iihbj_mglT4mrbKWD3B4-Sipi3h-7dBObwqB72-J__jLjxlt5A8tin585gd9etreIYEre-eD8_ibzj4Pk4
  priority: 102
  providerName: Directory of Open Access Journals
Title A novel preoperative plasma indicator to predict prognoses for patients with esophageal squamous cell carcinoma after radical esophagectomy: fibrinogen-to-lymphocyte ratio
URI https://www.ncbi.nlm.nih.gov/pubmed/31213896
https://www.proquest.com/docview/2243484794
https://pubmed.ncbi.nlm.nih.gov/PMC6536709
https://doaj.org/article/7eb121f007054d9fbce6d2eeaaf2bb4e
Volume 11
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3battAEB1ygZCX0HuVpmYLLX0oSr3S6lYoxQlJQ8GhpDX4Taz20hYcyZGUUn9Tf7Izkiws0rwY21rJWs_ZnbM7ozMArzMvNkiTrYtcXtPWjXGlENIVGQ90oEnyifYhp5fhxUx8mQfzLVhXG-3-wOq_SzuqJzUrF8d_blafcMB_pDRmLqL3p9PJ1fE3D7muH2_DLvqkiGoZTEUfTwjX8WWEn0vrrzYF_s7Z-7Dnk8ZZTBr-G36qkfO_O2lveK1hRuWGizp_AAcdt2STFgwPYcvkj2Bv2kXPH8PfCcuL32bBlqXBXraa32yJ_PlaMopdK1qBs7qgBvipZpS9lReVqRhyW9ZpsFaMNm-ZoQIIOBvhL1Y3t5K2EBiFAZii8kR5gddsCpCzUjaxoP4EVRfXqw_M0sMGeYEAduvCXawQVoVa1YY1mHwCs_Oz76cXbleswVUBj2rXJlahF-S-zkJuIh0kBud0KcJAj7nUaqyE8WUgNFICfGMtLoeN9JHhGS3QQ_pPYScvcvMcmMU5JAljnHwQNkrzOOZEXHimPT2O5diBd2vTpKpTMqeCGosUVzRk05RsmnY2deBN33rZKnjc0-6ErNy3Id3t5oui_JF2wziN0LV53JJIEnYlsZkyofawp9J6WSaMA28JIynhFW9Jye4hB-wY6WylE2SrFJgOIweOBi1xVKvB4VdrlKV0iFLhcoOWTJFz-SKmwgAOPGtR19_zGrwORAM8Djo1PJL_-tmIiodBI-V3eO81X8A-ksWkTfY8gp26vDUvkZDV2Qi2o3k0gt2Ts8uvV6NmWwNfP8_5qBmF_wD9iDps
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+novel+preoperative+plasma+indicator+to+predict+prognoses+for+patients+with+esophageal+squamous+cell+carcinoma+after+radical+esophagectomy%3A+fibrinogen-to-lymphocyte+ratio&rft.jtitle=Cancer+management+and+research&rft.au=Fan%2C+Ningbo&rft.au=Chen%2C+Dongni&rft.au=Zheng%2C+Jiabo&rft.au=Wen%2C+Zhesheng&rft.date=2019-05-01&rft.issn=1179-1322&rft.eissn=1179-1322&rft.volume=11&rft.spage=4719&rft_id=info:doi/10.2147%2FCMAR.S204938&rft_id=info%3Apmid%2F31213896&rft.externalDocID=31213896
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1179-1322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1179-1322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1179-1322&client=summon